首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷藥物遞輸設備電子醫療設備內視鏡檢查設備

市場調查報告書

商品編碼

1561493

2024-2032 年智慧藥丸市場報告（按目標領域、疾病適應症、應用、最終用戶和地區）

Smart Pills Market Report by Target Area, Disease Indication, Application, End User, and Region 2024-2032

出版日期: 2024年09月10日 | 出版商:

IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年全球智慧藥丸IMARC Group規模達46億美元。老年族群對慢性病管理的需求增加、技術的快速進步、微創手術（MIS）的新興趨勢、製藥業對個人化醫療和藥物輸送的日益關注是推動市場的一些主要因素。

智慧藥丸，也稱為數位藥丸或可攝入感測器，是一種創新藥物，配備微型電子元件，可實現遠端監控和資料收集。這些藥丸通常包含感測器、微晶片和發射器，供患者服用。一旦進入體內，它們就會與體液相互作用，將有關患者健康指標、藥物依從性和生理反應的即時資料發送到外部設備。醫療保健提供者和研究人員利用這些資料來加強患者護理、最佳化治療計劃和改善藥物開發。智慧藥丸透過增強監測和資料收集能力，為個人化醫療、慢性病管理和臨床試驗提供潛在好處。

在全球人口老化的推動下，全球智慧藥丸市場正在經歷大幅成長，導致慢性病盛行率增加，需要對患者的健康狀況進行持續監測和管理。智慧藥丸提供了一種非侵入性且有效的方式來收集即時健康資料，使其成為遠端患者監測和疾病管理的寶貴工具。此外，微型電子和無線通訊技術的進步使得開發和生產智慧藥丸更具成本效益，增加了醫療保健提供者和患者的可及性，這為市場擴張創造了積極的前景。除此之外，對個人化醫療的需求不斷成長以及對精確藥物輸送系統的需求促使製藥公司和研究人員投資智慧藥丸技術，也促進了市場的成長。此外，COVID-19 大流行推動了遠距醫療和遠端監控解決方案的採用，進一步推動了智慧藥丸市場的發展。

智慧藥丸市場趨勢/促進因素：

人口老化與慢性病管理

一個重要的促進因素是全球老年人口的增加。隨著人口平均年齡的增加，糖尿病、高血壓、心血管疾病等慢性疾病的盛行率也增加。管理這些狀況通常需要持續監測和堅持用藥。智慧藥丸透過提供有關患者健康指標的非侵入性即時資料收集來提供創新的解決方案。這種遠端監測功能對於難以採用傳統監測方法的老年患者尤其有價值。醫療保健提供者可以利用智慧藥丸的資料及時進行干預，調整治療計劃，並確保更好的疾病管理，從而提高老齡化人口的護理品質。

持續的技術進步

微型電子、感測器和無線通訊技術的進步極大地促進了智慧藥丸市場的成長。這些技術進步促進了更小、更容易服用的智慧藥丸的開發，提高了患者的舒適度和依從性，同時減少了服用過程中出現不適或阻力的可能性。此外，組件的小型化不僅降低了製造成本，還提高了智慧藥丸的整體效率和壽命。因此，醫療保健提供者和患者受益於更容易獲得和更具成本效益的解決方案，而智慧藥丸收集的資料的準確性和可靠性得到了提高，在醫學界得到了越來越多的認可，有助於市場擴張。

對個人化醫療和新型藥物輸送的需求不斷成長

製藥業對個人化醫療和精確藥物輸送系統日益成長的興趣是另一個促進因素。智慧藥丸提供了一種將藥物直接給藥到體內目標部位的獨特方法。這種標靶藥物傳遞可以增強治療效果，同時最大限度地減少副作用。製藥公司擴大投資智慧藥丸技術，作為改善藥物開發的手段，確保藥物適合個別患者的需求。除此之外，智慧藥丸還可用於臨床試驗，收集藥物效果的即時資料，簡化研究過程，並有可能加快新療法推向市場的速度。

The global smart pills market size reached US$ 4.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.9% during 2024-2032. The increased demand for chronic disease management among the geriatric population, rapid technological advancements, emerging trend of minimally invasive surgeries (MIS), the increasing focus of pharmaceutical industry on personalized medicine and drug delivery are some of the major factors propelling the market.

Smart pills, also known as digital pills or ingestible sensors, are innovative pharmaceuticals equipped with tiny electronic components that enable remote monitoring and data collection. These pills typically contain sensors, microchips, and transmitters, which are ingested by patients. Once inside the body, they interact with bodily fluids, sending real-time data about a patient's health metrics, medication adherence, and physiological responses to external devices. Healthcare providers and researchers use this data to enhance patient care, optimize treatment plans, and improve drug development. Smart pills offer potential benefits in personalized medicine, chronic disease management, and clinical trials by enhancing monitoring and data acquisition capabilities.

The global smart pills market is experiencing substantial growth driven by the aging population across the globe has resulted in an increased prevalence of chronic diseases, requiring continuous monitoring and management of patient's health. Smart pills offer a non-invasive and efficient way to collect real-time health data, making them a valuable tool for remote patient monitoring and disease management. Moreover, advancements in miniaturized electronics and wireless communication technologies have made it more cost-effective to develop and produce smart pills, increasing their accessibility to healthcare providers and patients, which is creating a positive outlook for market expansion. In addition to this, the rising demand for personalized medicine and the need for precise drug delivery systems prompting pharmaceutical companies and researchers to invest in smart pill technology, are contributing to the market growth. Furthermore, the COVID-19 pandemic has fueled the adoption of telehealth and remote monitoring solutions, further boosting the market for smart pills.

Smart Pills Market Trends/Drivers:

Aging population and chronic disease management

One significant driver is the increasing geriatric population across the globe. As the average age of the population rises, so does the prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular diseases. Managing these conditions often requires continuous monitoring and medication adherence. Smart pills provide an innovative solution by offering non-invasive, real-time data collection on a patient's health metrics. This remote monitoring capability is particularly valuable for elderly patients who may have difficulty with conventional monitoring methods. Healthcare providers can use the data from smart pills to make timely interventions, adjust treatment plans, and ensure better disease management, improving the quality of care for aging populations.

Ongoing technological advancements

Advancements in miniaturized electronics, sensors, and wireless communication technologies have significantly contributed to the growth of the smart pills market. These technological strides have led to the development of smaller, more easily ingestible smart pills, enhancing patient comfort and compliance while reducing the potential for discomfort or resistance during ingestion. Moreover, the miniaturization of components has not only reduced manufacturing costs but also improved the overall efficiency and longevity of smart pills. As a result, healthcare providers and patients benefit from more accessible and cost-effective solutions, while the enhanced accuracy and reliability of the data collected by smart pills have garnered increased acceptance within the medical community, aiding in market expansion.

Growing demand for personalized medicine and novel drug delivery

The pharmaceutical industry's growing interest in personalized medicine and precise drug delivery systems is another driving factor. Smart pills offer a unique way to administer medications directly to the target site in the body. This targeted drug delivery can enhance the efficacy of treatments while minimizing side effects. Pharmaceutical companies are increasingly investing in smart pill technology as a means to improve drug development, ensuring that medications are tailored to individual patient needs. Apart from this, smart pills can be used in clinical trials to gather real-time data on the drug's effects, streamlining the research process and potentially speeding up the introduction of new therapies to the market.

Smart Pills Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on target area, disease indication, application and end user.

Breakup by Target Area:

Esophagus
Small Intestine
Large Intestine
Stomach

Small intestine dominate the market

The report has provided a detailed breakup and analysis of the market based on the target area. This includes esophagus, small intestine, large intestine, and stomach. According to the report, small intestine represented the largest segment.

The demand for smart pills targeting the small intestine is propelled by their unique ability to access and monitor this specific area of the digestive tract. The small intestine plays a crucial role in nutrient absorption, making it a focal point for various gastrointestinal disorders and drug delivery challenges. Smart pills designed to operate in this region offer precise insights into nutrient absorption efficiency, allowing for tailored dietary recommendations and treatments for conditions, such as malabsorption syndromes. Furthermore, their application extends to drug delivery optimization, ensuring medications reach the intended site of action, which is especially relevant for treatments that require absorption in the small intestine. As a result, the demand for smart pills tailored to the small intestine continues to rise, driven by their potential to address specific healthcare needs and enhance therapeutic outcomes.

Breakup by Disease Indication:

Esophageal Diseases
Small Bowel Diseases
Colon Diseases
Others

A detailed breakup and analysis of the market based on the disease indication have also been provided in the report. This includes esophageal diseases, small bowel diseases, colon diseases, and others.

The surging demand for smart pills in addressing esophageal, small bowel, and colon diseases owing to their capacity to provide precise, real-time data in these specific areas of the gastrointestinal tract is strengthening the market growth. Moreover, the growing prevalence of esophageal diseases such as gastroesophageal reflux disease (GERD), wherein smart pills help monitor pH levels and track acid reflux patterns, aiding in the diagnosis and management of these conditions. Apart from this, in small bowel diseases like Crohn's disease or celiac disease, these pills can help track the passage and transit time, enabling clinicians to assess motility and inflammation, while in colon diseases, particularly colorectal cancer screening, smart pills equipped with imaging capabilities can capture detailed images, enhancing early detection and reducing the need for invasive procedures. This targeted monitoring and diagnostic potential are propelling the demand for smart pills in the context of esophageal, small bowel, and colon diseases, improving patient care and outcomes.

Breakup by Application:

Capsule Endoscopy
Drug Delivery
Patient Monitoring

Capsule endoscopy dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes capsule endoscopy, drug delivery, and patient monitoring. According to the report, capsule endoscopy represented the largest segment.

Unlike traditional endoscopy, smart pills equipped with imaging technology provide a painless and patient-friendly alternative for visualizing the gastrointestinal tract. This has led to increased acceptance and patient compliance, especially in cases where traditional endoscopy may be uncomfortable or challenging. Additionally, capsule endoscopy using smart pills is particularly valuable for diagnosing and monitoring conditions such as obscure gastrointestinal bleeding, Crohn's disease, and small bowel tumors. The high-quality images and real-time data captured by these smart pills allow for early detection and precise localization of abnormalities, thereby facilitating timely interventions and improving patient outcomes. Consequently, the demand for smart pills in capsule endoscopy continues to grow, enhancing the diagnostic capabilities of healthcare professionals and patient experiences.

Breakup by End User:

Hospitals
Diagnostic Centers
Research Institutes

Diagnostic centers hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, diagnostic centers, and research institutes. According to the report, diagnostic centers accounted for the largest market share.

The rising demand for smart pills in diagnostic centers is bolstering market expansion by offering a patient-friendly, non-invasive approach to enhance diagnostic procedures. These devices provide real-time gastrointestinal data, aiding precise diagnoses, especially for conditions like gastrointestinal bleeding, motility disorders, and small bowel diseases. Smart pills' imaging capabilities, pH assessment, and transit monitoring provide clinicians with a comprehensive view of GI health, reducing the need for uncomfortable invasive procedures. This improves patient comfort, compliance, and diagnostic accuracy, benefiting both patients and healthcare providers, and contributing to the growing adoption of smart pills in diagnostic centers.

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

North America exhibits a clear dominance, accounting for the largest smart pills market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's robust healthcare infrastructure, including advanced diagnostic centers and research institutions, is facilitating the adoption of smart pills for innovative diagnostic and research purposes. Concurrently, the increasing prevalence of gastrointestinal disorders, such as inflammatory bowel disease and colorectal cancer, has created a high demand for non-invasive diagnostic tools like smart pills, which offer improved patient comfort and compliance. Moreover, the region's aging population, with a growing need for chronic disease management, sees smart pills as an invaluable solution for remote patient monitoring. Besides this, favorable reimbursement policies and regulatory frameworks in North America are encouraging healthcare providers and pharmaceutical companies to invest in smart pill technology. Apart from this, the region's technological innovation and early market entry by leading companies have established a strong foundation for the growth of the North America smart pills market.

Competitive Landscape:

The global smart pills market presents a competitive landscape characterized by a mix of established players and emerging entrants striving to capitalize on the growing demand for remote patient monitoring and innovative healthcare solutions. Leading companies hold substantial market shares, primarily due to their early market entry, robust R&D capabilities, and extensive distribution networks. They offer a diverse range of smart pill products, incorporating advanced sensor technologies and data analytics platforms. Moreover, partnerships and collaborations with healthcare providers and pharmaceutical companies have further solidified their market position. At the same time, numerous startups and smaller companies, are actively contributing to market growth with disruptive technologies and novel applications of smart pills, intensifying competition and driving innovation in the industry.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

CapsoVision Inc
Check-Cap Ltd.
General Electric Company
IntroMedic Co. Ltd.
Jinshan Science & Technology (Group) Co. Ltd.
Koninklijke Philips N.V.
Medtronic plc
Olympus Corporation
PENTAX Medical (Hoya Corporation).

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In 2020, CapsoVision Inc. (US) attained ISO 27001 security certification for both its headquarters and CapsoCloud software, reaffirming its unwavering dedication to safeguarding customer data.

Key Questions Answered in This Report:

How has the global smart pills market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global smart pills market?
What is the impact of each driver, restraint, and opportunity on the global smart pills market?
What are the key regional markets?
Which countries represent the most attractive smart pills market?
What is the breakup of the market based on the target area?
Which is the most attractive target area in the smart pills market?
What is the breakup of the market based on the disease indication?
Which is the most attractive disease indication in the smart pills market?
What is the breakup of the market based on the application?
Which is the most attractive application in the smart pills market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the smart pills market?
What is the competitive structure of the global smart pills market?
Who are the key players/companies in the global smart pills market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Smart Pills Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Target Area

6.1 Esophagus
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Small Intestine
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Large Intestine
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Stomach
- 6.4.1 Market Trends
- 6.4.2 Market Forecast

7 Market Breakup by Disease Indication

7.1 Esophageal Diseases
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Small Bowel Diseases
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Colon Diseases
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Application

8.1 Capsule Endoscopy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Drug Delivery
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Patient Monitoring
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by End User

9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Diagnostic Centers
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Research Institutes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 CapsoVision Inc.
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 Check-Cap Ltd.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
- 15.3.3 General Electric Company
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 IntroMedic Co. Ltd.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
- 15.3.5 Jinshan Science & Technology (Group) Co. Ltd.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Koninklijke Philips N.V.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Medtronic plc
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Olympus Corporation
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 PENTAX Medical (Hoya Corporation)
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio

簡介目錄圖表

List of Figures

Figure 1: Global: Smart Pills Market: Major Drivers and Challenges
Figure 2: Global: Smart Pills Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Smart Pills Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Smart Pills Market: Breakup by Target Area (in %), 2023
Figure 5: Global: Smart Pills Market: Breakup by Disease Indication (in %), 2023
Figure 6: Global: Smart Pills Market: Breakup by Application (in %), 2023
Figure 7: Global: Smart Pills Market: Breakup by End User (in %), 2023
Figure 8: Global: Smart Pills Market: Breakup by Region (in %), 2023
Figure 9: Global: Smart Pills (Esophagus) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Smart Pills (Esophagus) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Smart Pills (Small Intestine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Smart Pills (Small Intestine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Smart Pills (Large Intestine) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Smart Pills (Large Intestine) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Smart Pills (Stomach) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Smart Pills (Stomach) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Smart Pills (Esophageal Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Smart Pills (Esophageal Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Smart Pills (Small Bowel Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Smart Pills (Small Bowel Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Smart Pills (Colon Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Smart Pills (Colon Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Smart Pills (Other Disease Indications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Smart Pills (Other Disease Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Smart Pills (Capsule Endoscopy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Smart Pills (Capsule Endoscopy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Smart Pills (Drug Delivery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Smart Pills (Drug Delivery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Smart Pills (Patient Monitoring) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Smart Pills (Patient Monitoring) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Smart Pills (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Smart Pills (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Smart Pills (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Smart Pills (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Smart Pills (Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Smart Pills (Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Canada: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Canada: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Asia-Pacific: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Asia-Pacific: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: China: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: China: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Japan: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Japan: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: India: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: India: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: South Korea: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: South Korea: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Australia: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Australia: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Indonesia: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Indonesia: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Europe: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Europe: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Germany: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Germany: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: France: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: France: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: United Kingdom: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: United Kingdom: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Italy: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Italy: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Spain: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Spain: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Russia: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Russia: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Latin America: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Latin America: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Brazil: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Brazil: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Mexico: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Mexico: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Middle East and Africa: Smart Pills Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Middle East and Africa: Smart Pills Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Smart Pills Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Smart Pills Industry: SWOT Analysis
Figure 87: Global: Smart Pills Industry: Value Chain Analysis
Figure 88: Global: Smart Pills Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Smart Pills Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Smart Pills Market Forecast: Breakup by Target Area (in Million US$), 2024-2032
Table 3: Global: Smart Pills Market Forecast: Breakup by Disease Indication (in Million US$), 2024-2032
Table 4: Global: Smart Pills Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Smart Pills Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Smart Pills Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Smart Pills Market: Competitive Structure
Table 8: Global: Smart Pills Market: Key Players

02-2729-4219

+886-2-2729-4219